The notices it replaced
- Reissues: PAR-14-184 National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01)
Replaced by PAR-18-230.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,076,696 in first-year total cost, median $1,076,696.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-C (04)]1
Most frequent institutions
- MOLECULAR NEUROIMAGING, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | A Program for Innovative PET Radioligand Development and Application - a translational toolbox for treatments for Mental Health1U01MH107803-01 · under PAR-14-184 | TAMAGNAN, GILLES D | MOLECULAR NEUROIMAGING, LLC, CT | $1,076,696 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.